Cataract Surgery Device Market Type, Product, Application and Growth Forecast to 2030 | MRFR
Global Cataract
Surgery Device Market Scenario:
Cataract Surgery Devices Market Size was
valued at USD 8.6 billion in 2022 and is projected to grow from USD 9.1 Billion
in 2023 to USD 12.23 billion by 2030, exhibiting a compound annual growth rate
(CAGR) of 5.19% during the forecast period (2022 - 2030). The global visual impairment population is
increasing gradually which is the primary
driving force behind the growth of the global
cataract surgery device market. Increasing prevalence of eye disorders,
especially cataract which necessitates surgery and, in turn, drives the market for cataract surgery device market. The
gradual rise in global geriatric population is also estimated to be a positive driving force for market growth. The
aging populace is more prone to developing cataract, and the demographic shift in developed countries towards older age
will lead to an increased rate of
cataract surgeries.
The economic upsurge in developing countries has directed the government’s attention towards
control and prevention of eye diseases, which has reflected positively on the
growth of the market. In addition,
development of minimally invasive surgical techniques and high-tech ophthalmic
surgical devices have propelled the growth of the global cataract surgery
device market. The emergence of laser
cataract surgery has also been a boon for the market. Furthermore, favorable reimbursement scenario for cataract
surgeries has raised the adoption rate of cataract surgeries which is
expected to boost the market growth over the forecast period. On the flip side,
the global cataract surgery devices market is expected to witness a setback in
developing countries where access to healthcare
is low. Moreover, low-income levels and
lack of awareness regarding eye impairments are significant
impediments to the growth of the global cataract surgery devices market.
Regional
Analysis
The global cataract surgery devices market report spans across the regions of North America,
Europe, Asia Pacific, Latin America, and
the Middle East & Africa.
North America is the largest
market for cataract surgery
devices and accounts for 46% share of the global market. Robust healthcare
sector, high expenditure on medical devices and rapid adoption of advanced technologies
supports the growth of the North America cataract surgery device market and is
expected to expand at a CAGR of 4.9% over the forecast period. Europe is the
second largest market for cataract surgery device market and is expected to
grow at a CAGR of 5.2% while Asia Pacific
is expected to grow at a relatively faster rate as compared to others. The
Latin America and Middle East & Africa markets are expected to exhibit
limited growth due to low penetration of healthcare.
Segmentation
The global cataract surgery device market has
been segmented based on device type and end-users. By device type, the market
has been segmented into intraocular lens (IOL), Ophthalmic Viscoelastic
Device (OVD), Phacoemulsification Equipment and Femtosecond Laser Equipment.
The intraocular lens (IOL) segment accounts for 79% share of the global market
and is poised to exhibit significant growth over the forecast period. By end users, the market has been segmented into
hospitals, clinics, ophthalmology centers, and others.
Competitive
Landscape
The global cataract surgery device market players
include Allergan, Inc. (U.S.), Essilor International S.A. (France), Bausch
& Lomb, Inc. (U.S.), STAAR Surgical Company (U.S.), Carl Zeiss Meditech AG
(Germany), Abbott Laboratories (U.S.), Opcon Corporation (Japan), NIDEK Co.,
Ltd. (Japan), and Alcon, Inc. (U.S).
Industry
Updates
·
In
August 2018, Alcon, a global leader in eye care and a subsidiary of Novartis,
announced a voluntary recall of CyPass
Micro-Stent, a micro-invasive eye surgical device due to safety concerns. The device was approved for use along with
cataract surgery but was pulled off the market following a five-year
post-surgery data analysis which indicates that it may cause damage to the
eyes.
·
In
September 2018, Swiss Advanced Vision launched a Harmonis customizable intraocular lens system designed for cataract
surgery.
About
Market Research Future:
At Market Research
Future (MRFR), we enable our customers to unravel the complexity of various
industries through our Cooked Research Report (CRR), Half-Cooked Research
Reports (HCRR), & Consulting Services. MRFR team have supreme objective to
provide the optimum quality market research and intelligence services to our
clients.
Contact
us:
Market Research
Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,
5Th Floor,
New York, New York
10013
United States of
America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment